Indraprastha Medical Corp Share Price
Sector: Healthcare Facilities
421.00 +3.25 (0.78%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
412.55
Today’s High
424.75
52 Week Low
212.25
52 Week High
571.95
418.35 +0.80 (0.19%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
412.50
Today’s High
424.65
52 Week Low
211.30
52 Week High
572.00
Key Metrics
- Market Cap (In Cr) 3870.63
- Beta 0.76
- Div. Yield (%) 1.08
- P/B 6.43
- TTM P/E 21.99
- Sector P/E 22.75
- D/E 0
- Open Price 420
- Prev Close 417.75
Indraprastha Medical Corp Analysis
Price Analysis
-
1 Week2.24%
-
3 Months3.86%
-
6 Month0.75%
-
YTD-19.99%
-
1 Year69.1%
Risk Meter
- 52% Low risk
- 52% Moderate risk
- 52% Balanced Risk
- 52% High risk
- 52% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 1
- 1
- 1
- 1
- Buy
- 0.00
- 0.00
- 0.00
- 0.00
- Hold
- 0.00
- 0.00
- 0.00
- 0.00
- Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Strong Sell
- 0.00
- 0.00
- 0.00
- 0.00
- Total
- 1
- 1
- 1
- 1
Indraprastha Medical Corp News
Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 17 Apr 2025Hospital stocks rise as govt plans daycare cancer centers in district hospitals
2 min read . 01 Feb 2025Breakout stocks to buy or sell: Sumeet Bagadia recommends five shares to buy
1 min read . 08 Jan 2025Indraprastha Medical Corp Q1 Results Live : profit rise by 46.79% YOY
1 min read . 06 Aug 2024Indraprastha Medical Corp Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 1244.7
- Selling/ General/ Admin Expenses Total
- 518.49
- Depreciation/ Amortization
- 40.08
- Other Operating Expenses Total
- 0.29
- Total Operating Expense
- 1090.25
- Operating Income
- 154.45
- Net Income Before Taxes
- 166.11
- Net Income
- 123.96
- Diluted Normalized EPS
- 13.62
- Period
- 2024
- Total Assets
- 723.24
- Total Liabilities
- 245.48
- Total Equity
- 477.76
- Tangible Book Valueper Share Common Eq
- 52
- Period
- 2024
- Cashfrom Operating Activities
- 200.15
- Cashfrom Investing Activities
- -158.43
- Cashfrom Financing Activities
- -32.38
- Net Changein Cash
- 9.34
- Period
- 2023
- Total Revenue
- 1098.67
- Selling/ General/ Admin Expenses Total
- 470.72
- Depreciation/ Amortization
- 39.27
- Other Operating Expenses Total
- 0.29
- Total Operating Expense
- 986.37
- Operating Income
- 112.3
- Net Income Before Taxes
- 117.18
- Net Income
- 86.15
- Diluted Normalized EPS
- 9.47
- Period
- 2023
- Total Assets
- 555.14
- Total Liabilities
- 175.69
- Total Equity
- 379.45
- Tangible Book Valueper Share Common Eq
- 41.29
- Period
- 2023
- Cashfrom Operating Activities
- 144.47
- Cashfrom Investing Activities
- -107.91
- Cashfrom Financing Activities
- -26.04
- Net Changein Cash
- 10.52
- Period
- 2022
- Total Revenue
- 888.16
- Selling/ General/ Admin Expenses Total
- 383.22
- Depreciation/ Amortization
- 34.94
- Other Operating Expenses Total
- 0.31
- Total Operating Expense
- 803.03
- Operating Income
- 85.13
- Net Income Before Taxes
- 79.07
- Net Income
- 58.62
- Diluted Normalized EPS
- 6.86
- Period
- 2022
- Total Assets
- 461.71
- Total Liabilities
- 136.27
- Total Equity
- 325.44
- Tangible Book Valueper Share Common Eq
- 35.31
- Period
- 2022
- Cashfrom Operating Activities
- 71.29
- Cashfrom Investing Activities
- -51.1
- Cashfrom Financing Activities
- -3.37
- Net Changein Cash
- 16.82
- Period
- 2021
- Total Revenue
- 613.38
- Selling/ General/ Admin Expenses Total
- 322.42
- Depreciation/ Amortization
- 33.32
- Other Operating Expenses Total
- 0.23
- Total Operating Expense
- 605.72
- Operating Income
- 7.66
- Net Income Before Taxes
- 4.29
- Net Income
- 2.33
- Diluted Normalized EPS
- 0.3
- Period
- 2021
- Total Assets
- 431.96
- Total Liabilities
- 159.2
- Total Equity
- 272.76
- Tangible Book Valueper Share Common Eq
- 29.38
- Period
- 2021
- Cashfrom Operating Activities
- 27.9
- Cashfrom Investing Activities
- -20.16
- Cashfrom Financing Activities
- -3.15
- Net Changein Cash
- 4.59
- Period
- 2020
- Total Revenue
- 830.77
- Selling/ General/ Admin Expenses Total
- 388.39
- Depreciation/ Amortization
- 32.99
- Other Operating Expenses Total
- 1.2
- Total Operating Expense
- 776.33
- Operating Income
- 54.44
- Net Income Before Taxes
- 48.19
- Net Income
- 43.62
- Diluted Normalized EPS
- 4.86
- Period
- 2020
- Total Assets
- 448.99
- Total Liabilities
- 181.19
- Total Equity
- 267.8
- Tangible Book Valueper Share Common Eq
- 29.06
- Period
- 2020
- Cashfrom Operating Activities
- 86.45
- Cashfrom Investing Activities
- -40.19
- Cashfrom Financing Activities
- -42.74
- Net Changein Cash
- 3.51
- Period
- 2019
- Total Revenue
- 788.17
- Selling/ General/ Admin Expenses Total
- 361.82
- Depreciation/ Amortization
- 29.75
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 735.72
- Operating Income
- 52.45
- Net Income Before Taxes
- 44.62
- Net Income
- 28.41
- Diluted Normalized EPS
- 3.2
- Period
- 2019
- Total Assets
- 422.37
- Total Liabilities
- 178.33
- Total Equity
- 244.04
- Tangible Book Valueper Share Common Eq
- 26.57
- Period
- 2019
- Cashfrom Operating Activities
- 75.19
- Cashfrom Investing Activities
- -16.7
- Cashfrom Financing Activities
- -44.18
- Net Changein Cash
- 14.3
- Period
- 2024-12-31
- Total Revenue
- 324.93
- Selling/ General/ Admin Expenses Total
- 72.18
- Depreciation/ Amortization
- 11.21
- Other Operating Expenses Total
- 58.34
- Total Operating Expense
- 283.95
- Operating Income
- 40.98
- Net Income Before Taxes
- 44.53
- Net Income
- 32.81
- Diluted Normalized EPS
- 3.58
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 349.82
- Selling/ General/ Admin Expenses Total
- 71.61
- Depreciation/ Amortization
- 11.17
- Other Operating Expenses Total
- 67.18
- Total Operating Expense
- 297.35
- Operating Income
- 52.47
- Net Income Before Taxes
- 56.93
- Net Income
- 42.4
- Diluted Normalized EPS
- 4.63
- Period
- 2024-09-30
- Total Assets
- 806.32
- Total Liabilities
- 281.89
- Total Equity
- 524.43
- Tangible Book Valueper Share Common Eq
- 57.12
- Period
- 2024-09-30
- Cashfrom Operating Activities
- 78.5
- Cashfrom Investing Activities
- -70.63
- Cashfrom Financing Activities
- -2.7
- Net Changein Cash
- 5.17
- Period
- 2024-06-30
- Total Revenue
- 347.86
- Selling/ General/ Admin Expenses Total
- 66.59
- Depreciation/ Amortization
- 11.04
- Other Operating Expenses Total
- 64.55
- Total Operating Expense
- 291.78
- Operating Income
- 56.08
- Net Income Before Taxes
- 59.59
- Net Income
- 44.77
- Diluted Normalized EPS
- 4.88
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 314.73
- Selling/ General/ Admin Expenses Total
- 64.79
- Depreciation/ Amortization
- 10.21
- Other Operating Expenses Total
- 65.93
- Total Operating Expense
- 276.5
- Operating Income
- 38.23
- Net Income Before Taxes
- 41.56
- Net Income
- 31.17
- Diluted Normalized EPS
- 3.4
- Period
- 2024-03-31
- Total Assets
- 723.24
- Total Liabilities
- 245.48
- Total Equity
- 477.76
- Tangible Book Valueper Share Common Eq
- 52
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 200.15
- Cashfrom Investing Activities
- -158.43
- Cashfrom Financing Activities
- -32.38
- Net Changein Cash
- 9.34
- Period
- 2023-12-31
- Total Revenue
- 306.46
- Selling/ General/ Admin Expenses Total
- 66.48
- Depreciation/ Amortization
- 10.03
- Other Operating Expenses Total
- 65.15
- Total Operating Expense
- 269.19
- Operating Income
- 37.27
- Net Income Before Taxes
- 40.67
- Net Income
- 29.44
- Diluted Normalized EPS
- 3.21
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Indraprastha Medical Corp Technical
Moving Average
SMA
- 5 Day424.51
- 10 Day406.42
- 20 Day408.71
- 50 Day387.69
- 100 Day424.33
- 300 Day418.61
Indraprastha Medical Corp Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Kovai Medical Cente And Hospital
- 5888.3
- 147.35
- 2.57
- 6400
- 3922.05
- 6496.31
- Thyrocare Technologies
- 980.45
- 31
- 3.27
- 1053.05
- 570.75
- 5194.94
- Indraprastha Medical Corp
- 421
- 3.25
- 0.78
- 571.95
- 212.25
- 3870.63
- Artemis Medicare Services
- 249.85
- -0.95
- -0.38
- 348.3
- 144.5
- 3456.38
- Shalby
- 201.5
- 1.8
- 0.9
- 325
- 177.25
- 2166.05
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Kovai Medical Cente And Hospital
- 34.9
- 7.07
- 19.28
- 12.23
- Thyrocare Technologies
- 55.81
- 9.24
- 20.87
- 17.91
- Indraprastha Medical Corp
- 30.66
- 8.01
- 19.59
- 6.73
- Artemis Medicare Services
- 47.27
- 4.12
- 9.91
- 5.88
- Shalby
- 25.58
- 2.15
- 6.37
- 8.2
Indraprastha Medical Corp Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 16-May-25
- Audited Results & Final Dividend
- 03-Feb-25
- Quarterly Results
- 30-Oct-24
- Quarterly Results
- 05-Aug-24
- Quarterly Results
- 17-May-24
- Audited Results & Final Dividend
- 06-Feb-24
- Quarterly Results
- 03-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results
- 23-May-23
- Audited Results & Dividend
- 08-Feb-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 21-Sept-23
- 04-Aug-23
- AGM
- 24-Sept-21
- 09-Aug-21
- AGM
- 24-Jul-21
- 23-Jun-21
- POM
- -
- 07-Aug-24
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 16-May-25
- -
- -
- 4.5
- 17-May-24
- -
- 13-Sept-24
- 4.5
- 23-May-23
- -
- 15-Sept-23
- 3


